Stock listing

NASDAQ:YDES YD Bio Limited Stock

Home listing (NASDAQ) of YD Bio Limited

Follow YD Bio Limited into a list and get an email when it puts out news.

Share price · NASDAQ:YDES

$4.83 USD -0.02 (-0.4%)

Close on Nov 20, 2026

Past year -42.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$4.36 – $4.95 USDNov 20, 2026
Volume
29,790 sharesNov 20, 2026
Market cap
$342.1M USDAt the close on Nov 20, 2026 · price × 70.83M shares outstanding
52-week range
$1.70 – $15.72 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.45M USDMedian day 178,100 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
YD Bio Limited logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:YDES · Home$4.83 USD-0.02 (-0.4%)29,790$4.80$4.95$4.36$4.85Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:YDES · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$4.83-0.02-0.4%$4.80$4.95$4.3629,790
$4.85+0.12+2.5%$4.85$5.265$4.8021,488
$4.73-0.10-2.1%$4.68$5.00$4.6235,910
$4.83-0.05-1.0%$5.00$5.10$4.25120,921
$4.88-0.315-6.1%$5.08$5.45$4.8825,888
$5.195-0.955-15.5%$6.16$6.16$5.1179,310
$6.15+0.12+2.0%$6.22$6.29$6.01413,286
$6.03-0.68-10.1%$6.50$6.95$5.90103,131
$6.71+0.74+12.4%$6.40$6.905$6.2040,154
$5.97-1.21-16.9%$7.01$7.45$5.87206,967
$7.18+0.23+3.3%$6.60$7.28$6.5676,917
$6.95+0.555+8.7%$6.20$7.14$6.02881,397
$6.395+0.425+7.1%$5.81$6.48$5.8122,833
$5.97+0.03+0.5%$5.90$6.34$5.69180,207
$5.94+0.07+1.2%$5.99$6.10$5.6747,346
$5.87-0.41-6.5%$6.31$6.60$5.8396,182
$6.28+0.24+4.0%$6.02$6.496$5.92283,872
$6.04+0.75+14.2%$5.30$6.15$5.2947,052
$5.29+0.34+6.9%$5.065$5.43$4.8759,168
$4.95+0.71+16.7%$4.28$5.10$4.135105,100
$4.24-1.53-26.5%$5.85$6.04$4.15180,400
$5.77-0.07-1.2%$5.89$6.30$5.60144,100
$5.84-0.28-4.6%$6.08$6.565$5.61178,100
$6.12+0.20+3.4%$5.92$6.26$5.4692,500
$5.92-0.82-12.2%$6.67$7.05$5.82153,400
$6.74+0.38+6.0%$6.30$6.87$6.3072,300
$6.36+0.26+4.3%$6.16$6.47$6.0020,400
$6.10-0.23-3.6%$6.33$6.51$6.0023,600
$6.33-0.40-5.9%$7.01$7.13$6.10138,100
$6.73+0.94+16.2%$5.71$7.09$5.61207,700
$5.79-0.09-1.5%$5.81$6.20$5.53149,000
$5.88-0.27-4.4%$6.22$6.38$5.632135,900
$6.15-0.96-13.5%$6.94$7.10$5.20439,700
$7.11-1.00-12.3%$7.90$8.03$6.81258,500
$8.11+0.30+3.8%$7.71$8.43$6.60546,600
$7.81+0.39+5.3%$7.18$8.25$6.99267,900
$7.42-0.19-2.5%$7.59$7.73$6.80205,000
$7.61+0.50+7.0%$7.03$7.89$6.62347,100
$7.11+1.38+24.1%$6.13$7.35$5.62507,600
$5.73+0.96+20.1%$4.77$5.88$4.548654,000
$4.77+1.54+47.7%$3.26$5.41$3.263,172,000
$3.23+0.41+14.5%$2.78$3.34$2.42359,100
$2.82+0.19+7.2%$2.67$3.10$2.60390,300
$2.63-0.56-17.6%$3.11$3.35$2.51662,600
$3.19-0.05-1.5%$3.25$3.57$3.15535,500
$3.24-0.46-12.4%$3.70$3.76$3.12544,500
$3.70-0.25-6.3%$3.90$3.90$3.265695,500
$3.95+0.12+3.1%$3.79$4.04$3.66688,700
$3.83-0.17-4.2%$4.01$4.01$3.61523,300
$4.00+0.10+2.6%$3.93$4.187$3.61819,300
$3.90-0.025-0.6%$3.82$4.31$3.729633,200
$3.925-0.325-7.6%$4.36$4.38$3.65729,600
$4.25+0.71+20.1%$3.72$4.50$3.65502,800
$3.54-0.13-3.5%$3.67$3.88$3.29687,100
$3.67-0.09-2.4%$3.64$4.05$3.21672,100
$3.76-0.015-0.4%$3.71$4.015$3.50567,600
$3.775+0.065+1.8%$3.77$4.08$3.36428,700
$3.71-1.09-22.7%$4.87$4.87$3.10445,300
$4.80+0.93+24.0%$3.94$4.80$3.09217,800
$3.87-0.47-10.8%$4.34$4.34$3.8027,100
$4.34-0.34-7.3%$4.85$4.85$4.0011,400
$4.68+0.02+0.4%$4.75$4.77$4.0979,659
$4.66-0.03-0.6%$4.66$4.767$4.45518,536
$4.69-0.096-2.0%$4.56$5.00$4.4035,500
$4.786+0.316+7.1%$4.39$4.99$4.009104,800
Ticker
NASDAQ:YDES
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All YD Bio Limited news

YD Bio Limited on 6ix

News releases
19 in the last 12 months · 24 in all · newest Nov 12, 2026 · oldest 2025
Decks
1 deck · latest Jan 15, 2026

Where YD Bio Limited is listed

ListingExchangeCountryCurrency
NASDAQ:YDES · Home listing · This pageNASDAQUnited StatesUSD
BOATS:YDESBOATSUnited StatesUSD

Valuation

Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$339.5M USD
P/E
Loss
EV/sales
569×
EV/EBITDA
Negative EBITDA
Price/book
76.5×
Gross margin
28.1%
Operating margin
−883.3%
Net margin
Revenue too small
Debt to equity
0.0×
Beta vs S&P 500
0.25

Team and board

Officers

OfficerRole
Ethan ShenChairman & CEO
Edmund HenCFO

Board

DirectorRole
Ethan ShenChairman & CEO

Events

QuarterResults
Q1 2025Apr 30, 2025
Q3 2024Nov 25, 2024

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (January 2026)Investor deck26 slidesJan 15, 2026

Open Decks

Financings

RaiseDate
Private placement of pIPE offering securities
Closed: private placement
Use of proceeds: To fund the Company's future operations
Aug 29, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue596.8K510.4K350.1K
Cost of revenue429.4K355.0K196.7K
Gross profit167.4K155.4K153.4K
Research and development1.60M491.4K0
Selling, general and administrative3.82M1.12M153.1K
Operating income-5.27M-1.46M-9.85K-2.32M-1.72M-344.2K
Depreciation and amortization16.2K10.2K2.45K
EBITDA-5.26M-1.45M-7.39K
Interest expense07722.14K
Income before tax-8.31M-1.39M17.6K3.79M8.70M-2.54M
Income tax-1.53K25.1K4.09K2.09K
Net income-8.31M-1.41M13.6K3.79M8.70M-2.54M
Earnings per share, basic-0.12-0.020.000.410.59-0.17
Earnings per share, diluted-0.12-0.020.00

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents6.01M3.13M87.1K14.1K5.40K693.8K
Receivables167.5K86.6K98.4K18.1K
Inventory1.88M37.3K69.4K
Current assets9.67M3.47M271.7K202.7K129.6K830.8K
Property, plant and equipment59.3K64.4K
Total assets13.8M6.86M321.2K17.9M118.1M117.6M
Accounts payable413.3K26.9K18.0K
Current liabilities1.64M263.1K298.2K5.55M2.00M302.2K
Long-term debt6.76K
Total debt6.76K22.6K47.6K
Total liabilities16.6M274.0K298.2K6.74M9.11M17.8M
Shareholders' equity-2.86M6.59M23.0K11.2M109.0M99.8M
Shares outstanding70.8M64.7M70.8M9.29M14.6M14.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-6.60M-1.22M-55.7K-3.02M-688.4K-253.6K
Capital spending-1.44M-74.9K-2900-5-5
Free cash flow-8.04M-1.30M-55.9K-3.02M-688.4K-253.6K
Cash from investing-1.44M-2.90M-290100.4M-1.15M-116.7M
Cash from financing10.9M7.11M113.9K-97.3M1.15M117.7M
Share buybacks-101.5M
Change in cash2.88M3.05M57.0K8.73K-688.4K693.8K

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipOct 6, 2026Insider tradeSEC
4 · Change in ownershipOct 6, 2026Insider tradeSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
4 · Change in ownershipSep 10, 2026Insider tradeSEC
4 · Change in ownershipSep 8, 2026Insider tradeSEC
424B3 · ProspectusAug 31, 2026Offer documentSEC
6-K · Report of a foreign issuerAug 31, 2026Current reportSEC
424B3 · ProspectusAug 11, 2026Offer documentSEC
6-K · Report of a foreign issuerAug 11, 2026Current reportSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
All 80 filings
FilingDateTypeFiled with
4 · Change in ownershipJul 1, 2026Insider tradeSEC
EFFECT · Notice that a registration is effectiveJun 1, 2026Other filingsSEC
POS AM · Amendment to an effective registrationMay 26, 2026Offer documentSEC
6-K · Report of a foreign issuerApr 30, 2026Current reportSEC
20-F · Annual reportApr 30, 2026Annual reportSEC
3/A · Initial statement of ownership, amendedApr 20, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 2, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 2, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 30, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 26, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
424B3 · ProspectusFeb 27, 2026Offer documentSEC
6-K · Report of a foreign issuerFeb 26, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
424B3 · ProspectusFeb 5, 2026Offer documentSEC
6-K · Report of a foreign issuerJan 30, 2026Current reportSEC
6-K · Report of a foreign issuerJan 20, 2026Current reportSEC
6-K · Report of a foreign issuerJan 15, 2026Current reportSEC
6-K · Report of a foreign issuerJan 15, 2026Current reportSEC
6-K · Report of a foreign issuerJan 6, 2026Current reportSEC
S-8 · Registration statement for employee plansJan 2, 2026Offer documentSEC
SCHEDULE 13G · Big-stake noticeDec 16, 2025Big-stake noticeSEC
424B3 · ProspectusNov 17, 2025Offer documentSEC
6-K · Report of a foreign issuerNov 17, 2025Current reportSEC
F-1/A · Registration statement, amendedOct 24, 2025Offer documentSEC
6-K · Report of a foreign issuerSep 30, 2025Current reportSEC
UPLOAD · Letter from the SECSep 29, 2025Other filingsSEC
6-K · Report of a foreign issuerSep 26, 2025Current reportSEC
F-1 · Registration statementSep 23, 2025Offer documentSEC
6-K · Report of a foreign issuerSep 19, 2025Current reportSEC
20FR12BSep 5, 2025Other filingsSEC
CERT · Exchange's certificate of listingAug 28, 2025Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeAug 20, 2025Other filingsSEC
6-K · Report of a foreign issuerAug 15, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveJul 21, 2025Other filingsSEC
424B3 · ProspectusJul 18, 2025Offer documentSEC
CORRESP · Letter to the SECJul 16, 2025Other filingsSEC
F-4/AJul 15, 2025Offer documentSEC
CORRESP · Letter to the SECJul 10, 2025Other filingsSEC
F-4/AJul 10, 2025Offer documentSEC
UPLOAD · Letter from the SECJul 9, 2025Other filingsSEC
CORRESP · Letter to the SECJul 7, 2025Other filingsSEC
F-4/AJul 7, 2025Offer documentSEC
UPLOAD · Letter from the SECJul 3, 2025Other filingsSEC
CORRESP · Letter to the SECJun 30, 2025Other filingsSEC
F-4/AJun 30, 2025Offer documentSEC
UPLOAD · Letter from the SECJun 18, 2025Other filingsSEC
CORRESP · Letter to the SECJun 4, 2025Other filingsSEC
F-4/AJun 4, 2025Offer documentSEC
UPLOAD · Letter from the SECMay 15, 2025Other filingsSEC
CORRESP · Letter to the SECApr 30, 2025Other filingsSEC
F-4/AApr 30, 2025Offer documentSEC
UPLOAD · Letter from the SECApr 3, 2025Other filingsSEC
CORRESP · Letter to the SECMar 17, 2025Other filingsSEC
F-4/AMar 17, 2025Offer documentSEC
UPLOAD · Letter from the SECFeb 14, 2025Other filingsSEC
F-4/AJan 30, 2025Offer documentSEC
CORRESP · Letter to the SECJan 29, 2025Other filingsSEC
UPLOAD · Letter from the SECJan 16, 2025Other filingsSEC
SEC STAFF ACTIONJan 13, 2025Other filingsSEC
F-4/ADec 20, 2024Offer documentSEC
F-4/ADec 17, 2024Offer documentSEC
F-4Nov 25, 2024Offer documentSEC
425Jun 21, 2024Other filingsSEC
425Mar 20, 2024Other filingsSEC
425Mar 15, 2024Other filingsSEC
S-4 · Registration statementFeb 14, 2024Offer documentSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from YD Bio Limited’s releases · as of Aug 29, 2025

Common shares
70,831,346
Fully diluted
70,831,346

Fully diluted

LineShares
Common shares70,831,346

Share count over time

CountShares
Nov 22, 202670,831,346

Open Cap table

Shareholders

Institutions

HolderSharesValueChange vs Jun 30Filed
Cerity Partners LLC107KUS$797K+75,000Nov 13, 2026
Garrett Wealth Advisory Group, LLC84,630US$628KNo changeOct 22, 2026
Jane Street78,322US$581K+56,899Nov 12, 2026
Millennium48,546US$360KNewNov 16, 2026
Geode Capital44,942US$333K−17,772Nov 6, 2026
Cypress Capital Management LLC (WY)29,970US$222K−3,720Nov 9, 2026
UBS29,086US$216K+16,702Nov 10, 2026
Hrt Financial LP21,837US$162KNewNov 13, 2026
XTX Topco Ltd18,321US$136KNewNov 16, 2026
Morgan Stanley549US$4,074+389Nov 13, 2026
All 13 holders
HolderSharesValueChange vs Jun 30Filed
Wells Fargo75US$557No changeNov 16, 2026
RBC17−100Nov 16, 2026
JPMorgan5US$38NewNov 12, 2026

Funds

HolderSharesValueChangeAs of
Fidelity Nasdaq Composite Index Fund40,627US$123K+1,348May 31, 2026
Fidelity Nasdaq Composite Index ETF22,725US$68,630+1,798May 31, 2026

Insider trades

InsiderTradeSharesPriceValueDate
Shen Ethan PhD
Director, Officer: CEO
Buy12,700USD 3.85US$48,895Sep 14, 2026
Shen Ethan PhD
Director, Officer: CEO
Buy3,100USD 3.93US$12,183Sep 9, 2026
Shen Ethan PhD
Director, Officer: CEO
Buy18,378USD 3.67US$67,447Sep 4, 2026

Big stakes

HolderStakeSharesDate
Ethan Shen77.06%54.3MFeb 17, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Ethan Shen
Other companies: SL Science Holding Ltd (Chief Technology Officer (CTO) · Since at least Jun 12, 2026); Horizon Space Acquisition II Corp. (Chief Technology Officer (CTO) · Since at least May 12, 2025)
Chairman & CEO · Since at least Mar 18, 2026
Bo-Xiang ZhangChief Medical Officer, Director · Since at least Mar 18, 2026
Edmund HenCFO · Since at least Nov 5, 2026
Jerry Yin-Chia LeeDirector · Since at least Mar 18, 2026
Kochi ChangDirector · Since at least Mar 18, 2026
Man Edmund HenChief Financial Officer · Since at least Mar 18, 2026
Shao-Ta LuDirector · Since at least Mar 18, 2026

Open People

Log in to ask 6ix AI your own questions about YD Bio Limited.